Research Calls I
-
Upgrades:
- Albertsons (ACI) upgraded to Buy from Hold at Melius; tgt $24
- Ally Financial (ALLY) upgraded to Mkt Perform from Underperform at Raymond James
- Getty Realty Corp. (GTY) upgraded to Buy from Neutral at BofA Securities; tgt raised to $34
- Gilead Sciences (GILD) upgraded to Outperform from Market Perform at Leerink Partners; tgt raised to $96
- GitLab (GTLB) upgraded to Buy from Hold at Needham; tgt $70
- Healthpeak Properties (DOC) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $28
- Home Bancorp (HBCP) upgraded to Outperform from Mkt Perform at Raymond James; tgt $50
-
Downgrades:
- Canada Goose (GOOS) downgraded to Sell from Neutral at Goldman; tgt lowered to $9
- Centerspace (CSR) downgraded to Mkt Perform from Outperform at Raymond James
- Essex Property (ESS) downgraded to Mkt Perform from Outperform at Raymond James
- Extra Space Storage (EXR) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $175
- HCI Group (HCI) downgraded to Neutral from Buy at Compass Point; tgt raised to $120
- Hilton (HLT) downgraded to Hold from Buy at Melius
-
Others:
- BioAge Labs (BIOA) initiated with an Overweight at Morgan Stanley; tgt $40
- BioAge Labs (BIOA) initiated with a Buy at Jefferies; tgt $42
- BKV Corporation (BKV) initiated with an Overweight at Barclays; tgt $24
- BKV Corporation (BKV) initiated with an Outperform at Mizuho; tgt $29
- BKV Corporation (BKV) initiated with an Overweight at KeyBanc Capital Markets; tgt $23
- BKV Corporation (BKV) initiated with a Buy at Jefferies; tgt $28
- Capricor Therapeutics (CAPR) initiated with an Overweight at Piper Sandler; tgt $35
- Eagle Bancorp (EGBN) resumed with a Neutral at Piper Sandler; tgt $27
- Elme Communities (ELME) initiated with a Peer Perform at Wolfe Research
- Esco Tech (ESE) initiated with a Buy at The Benchmark Company; tgt $150
- GE Vernova (GEV) initiated with a Buy at Deutsche Bank; tgt $354
- Guardian Pharmacy (GRDN) Services initiated with a Buy at Truist; tgt $22
- Harmony Gold (HMY) resumed with a Neutral at BofA Securities